These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 18996964)
1. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T Eur J Endocrinol; 2009 Feb; 160(2):265-73. PubMed ID: 18996964 [TBL] [Abstract][Full Text] [Related]
2. Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T Calcif Tissue Int; 2008 Nov; 83(5):324-31. PubMed ID: 18946627 [TBL] [Abstract][Full Text] [Related]
3. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women. Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738 [TBL] [Abstract][Full Text] [Related]
4. Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T Osteoporos Int; 2007 Dec; 18(12):1675-81. PubMed ID: 17632742 [TBL] [Abstract][Full Text] [Related]
5. Baseline serum total adiponectin level is positively associated with changes in bone mineral density after 1-year treatment of type 2 diabetes mellitus. Kanazawa I; Yamaguchi T; Sugimoto T Metabolism; 2010 Sep; 59(9):1252-6. PubMed ID: 20045535 [TBL] [Abstract][Full Text] [Related]
6. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Yamaguchi T; Kanazawa I; Yamamoto M; Kurioka S; Yamauchi M; Yano S; Sugimoto T Bone; 2009 Aug; 45(2):174-9. PubMed ID: 19446053 [TBL] [Abstract][Full Text] [Related]
7. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Tanaka KI; Kanazawa I; Kaji H; Sugimoto T Bone; 2017 Feb; 95():5-10. PubMed ID: 27836731 [TBL] [Abstract][Full Text] [Related]
8. Relationships between dimethylarginine and the presence of vertebral fractures in type 2 diabetes mellitus. Kanazawa I; Yano S; Yamaguchi T; Notsu Y; Nabika T; Sugimoto T Clin Endocrinol (Oxf); 2010 Oct; 73(4):463-8. PubMed ID: 20550537 [TBL] [Abstract][Full Text] [Related]
9. Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes. Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T Calcif Tissue Int; 2009 Sep; 85(3):228-34. PubMed ID: 19641839 [TBL] [Abstract][Full Text] [Related]
10. Serum adiponectin, bone mineral density and bone turnover markers in post-menopausal women with newly diagnosed Type 2 diabetes: a 12-month follow-up. Miazgowski T; Noworyta-Ziętara M; Safranow K; Ziemak J; Widecka K Diabet Med; 2012 Jan; 29(1):62-9. PubMed ID: 21726281 [TBL] [Abstract][Full Text] [Related]
11. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. Yamamoto M; Yamaguchi T; Yamauchi M; Yano S; Sugimoto T J Clin Endocrinol Metab; 2008 Mar; 93(3):1013-9. PubMed ID: 18160470 [TBL] [Abstract][Full Text] [Related]
12. In postmenopausal female subjects with type 2 diabetes mellitus, vertebral fractures are independently associated with cortisol secretion and sensitivity. Zhukouskaya VV; Eller-Vainicher C; Gaudio A; Cairoli E; Ulivieri FM; Palmieri S; Morelli V; Orsi E; Masserini B; Barbieri AM; Polledri E; Fustinoni S; Spada A; Fiore CE; Chiodini I J Clin Endocrinol Metab; 2015 Apr; 100(4):1417-25. PubMed ID: 25590217 [TBL] [Abstract][Full Text] [Related]
13. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial. Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170 [TBL] [Abstract][Full Text] [Related]
14. Association of Bone Mineral Density, Bone Turnover Markers, and Vertebral Fractures with All-Cause Mortality in Type 2 Diabetes Mellitus. Miyake H; Kanazawa I; Sugimoto T Calcif Tissue Int; 2018 Jan; 102(1):1-13. PubMed ID: 28965188 [TBL] [Abstract][Full Text] [Related]
15. Risk of vertebral fractures in men: relationship to mineral density of the vertebral body. Resch A; Schneider B; Bernecker P; Battmann A; Wergedal J; Willvonseder R; Resch H AJR Am J Roentgenol; 1995 Jun; 164(6):1447-50. PubMed ID: 7754890 [TBL] [Abstract][Full Text] [Related]
16. Bone mineral density and vertebral fractures in men. Legrand E; Chappard D; Pascaretti C; Duquenne M; Rondeau C; Simon Y; Rohmer V; Basle MF; Audran M Osteoporos Int; 1999; 10(4):265-70. PubMed ID: 10692973 [TBL] [Abstract][Full Text] [Related]
17. Decreased Serum Insulin-like Growth Factor-I is a Risk Factor for Non-vertebral Fractures in Diabetic Postmenopausal Women. Miyake H; Kanazawa I; Sugimoto T Intern Med; 2017; 56(3):269-273. PubMed ID: 28154269 [TBL] [Abstract][Full Text] [Related]
18. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women. Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051 [TBL] [Abstract][Full Text] [Related]
19. The relationship between bone density and incident vertebral fracture in men and women. J Bone Miner Res; 2002 Dec; 17(12):2214-21. PubMed ID: 12469915 [TBL] [Abstract][Full Text] [Related]
20. Discordance between Prevalent Vertebral Fracture and Vertebral Strength Estimated by the Finite Element Method Based on Quantitative Computed Tomography in Patients with Type 2 Diabetes Mellitus. Kiyohara N; Yamamoto M; Sugimoto T PLoS One; 2015; 10(12):e0144496. PubMed ID: 26642210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]